Why is Morepen Labs. falling/rising?

As of 18-Aug, Morepen Laboratories Ltd is experiencing a price increase, currently at Rs 48.10, reflecting a rise of 1.69 (3.64%). The stock has outperformed its sector today by 3.41%, reaching an intraday high of Rs 48.15. However, despite this short-term gain, the stock has shown a significant decline of 23.13% over the past month and a year-to-date drop of 38.57%. The company has reported a low Debt to Equity ratio and an attractive valuation with a Price to Book Value of 2.3, but it has also faced challenges, including a 21.3% fall in profits and negative results for the last two consecutive quarters, which may contribute to investor caution.
In the broader market context, the stock's short-term performance of +2.51% over the past week contrasts with the Sensex's modest gain of +0.83%, indicating some relative strength. However, the stock's long-term performance is concerning, with a decline of 20.95% over the past year, underperforming the BSE500 index. The lack of domestic mutual fund investment, holding only 0% of the company, suggests a lack of confidence in its future prospects, which could weigh on its price despite recent gains.